Back to Search
AIMEE TRUESDALE, MD
MD
Hepatology Physician
NPI: 1811034176IndividualAccepts Medicare
Specialties, Licenses & Credentials
Gastroenterology Physician
Internal Medicine — Gastroenterology
Code: 207RG0100X
45076(CO)
Hepatology PhysicianPrimary
Internal Medicine — Hepatology
Code: 207RI0008X
45076(CO)
CMS Specialties
PrimaryGASTROENTEROLOGY
Education
OTHER
Class of 2004
Research & Publications (20)
Discovery of an inhibitor of insulin-like growth factor 1 receptor activation: implications for cellular potency and selectivity over insulin receptor.
PMID 19665448·Biochem Pharmacol·2009
7-preclinical
Discovery of 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitor.
PMID 18620382·J Med Chem·2008
7-preclinical
Methods of data collection and analysis for the economic evaluation alongside a national, multi-centre trial in the UK: conventional ventilation or ECMO for Severe Adult Respiratory Failure (CESAR).
PMID 18447931·BMC Health Serv Res·2008
4-observational
The INNOVO multicentre randomised controlled trial: neonatal ventilation with inhaled nitric oxide versus ventilatory support without nitric oxide for severe respiratory failure in preterm infants: follow up at 4-5 years.
PMID 18375612·Arch Dis Child Fetal Neonatal Ed·2008
4-observational
Impact of common epidermal growth factor receptor and HER2 variants on receptor activity and inhibition by lapatinib.
PMID 18199554·Cancer Res·2008
4-observational
Design and effective synthesis of novel templates, 3,7-diphenyl-4-amino-thieno and furo-[3,2-c]pyridines as protein kinase inhibitors and in vitro evaluation targeting angiogenetic kinases.
PMID 17027260·Bioorg Med Chem Lett·2007
7-preclinical
Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004.
PMID 18055720·Obstet Gynecol·2007
8-other
Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity.
PMID 17620431·Mol Cancer Ther·2007
7-preclinical
Neonatal ventilation with inhaled nitric oxide vs. ventilatory support without inhaled nitric oxide for infants with severe respiratory failure born at or near term: the INNOVO multicentre randomised controlled trial.
PMID 17344656·Neonatology·2007
4-observational
Orally active 4-amino-5-diarylurea-furo[2,3-d]pyrimidine derivatives as anti-angiogenic agent inhibiting VEGFR2 and Tie-2.
PMID 17276055·Bioorg Med Chem Lett·2007
7-preclinical
CESAR: conventional ventilatory support vs extracorporeal membrane oxygenation for severe adult respiratory failure.
PMID 17187683·BMC Health Serv Res·2006
2-rct
Discovery of a novel and potent series of dianilinopyrimidineurea and urea isostere inhibitors of VEGFR2 tyrosine kinase.
PMID 15990302·Bioorg Med Chem Lett·2005
8-other
Neonatal Ventilation With Inhaled Nitric Oxide Versus Ventilatory Support Without Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure: the INNOVO multicentre randomised controlled trial (ISRCTN 17821339).
PMID 15805366·Pediatrics·2005
3-trial
A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells.
PMID 15374980·Cancer Res·2004
8-other
Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour models.
PMID 15328520·Br J Cancer·2004
7-preclinical
4-Acylamino-6-arylfuro[2,3-d]pyrimidines: potent and selective glycogen synthase kinase-3 inhibitors.
PMID 15225695·Bioorg Med Chem Lett·2004
8-other
Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial.
PMID 12387959·Lancet·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 499 E HAMPDEN AVE STE 420
ENGLEWOOD, CO 80113 - Phone
- (303) 788-8888
Quick Facts
- NPI
- 1811034176
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 22
- Publications
- 20
Are you this provider?
Claim Your Profile